Abstract
On January 21, 2011, the U.S. Food and Drug Administration approved Viibryd, a new selective serotonin reuptake inhibitor (SSRI), to treat major depressive disorder in adults developed by Clinical Data, Inc.
Original language | English (US) |
---|---|
Pages (from-to) | 554 |
Number of pages | 1 |
Journal | ACS Chemical Neuroscience |
Volume | 2 |
Issue number | 10 |
DOIs | |
State | Published - Oct 19 2011 |
Externally published | Yes |
Keywords
- Depression
- SSRI
- antidepressant
- major depressive disorder
ASJC Scopus subject areas
- Biochemistry
- Physiology
- Cognitive Neuroscience
- Cell Biology